Related references
Note: Only part of the references are listed.Epidemiology of sepsis in cancer patients in Victoria, Australia: a population-based study using linked data
Luc te Marvelde et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH (2020)
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study
Kristina E. Rudd et al.
LANCET (2020)
PART III: MINIMUM QUALITY THRESHOLD IN PRECLINICAL SEPSIS STUDIES (MQTiPSS) FOR FLUID RESUSCITATION AND ANTIMICROBIAL THERAPY ENDPOINTS
Judith Hellman et al.
SHOCK (2019)
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
Takahiro Kamada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
2B4 but not PD-1 blockade improves mortality in septic animals with preexisting malignancy
Ching-Wen Chen et al.
JCI INSIGHT (2019)
MINIMUM QUALITY THRESHOLD IN PRE-CLINICAL SEPSIS STUDIES (MQTiPSS): AN INTERNATIONAL EXPERT CONSENSUS INITIATIVE FOR IMPROVEMENT OF ANIMAL MODELING IN SEPSIS
Marcin F. Osuchowski et al.
SHOCK (2018)
JunB regulates homeostasis and suppressive functions of effector regulatory T cells
Shin-ichi Koizumi et al.
NATURE COMMUNICATIONS (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Anti-PD-L1 peptide improves survival in sepsis
Yuichiro Shindo et al.
JOURNAL OF SURGICAL RESEARCH (2017)
CXCR4 blockade decreases CD4+ T cell exhaustion and improves survival in a murine model of polymicrobial sepsis
Kimberly M. Ramonell et al.
PLOS ONE (2017)
The immunopathology of sepsis and potential therapeutic targets
Tom van der Poll et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes et al.
CRITICAL CARE MEDICINE (2017)
Helios Controls a Limited Subset of Regulatory T Cell Functions
Mathew Sebastian et al.
JOURNAL OF IMMUNOLOGY (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1
Andriani C. Patera et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
TIGIT and PD-1 impair tumor antigen-specific CD8+ T cells in melanoma patients
Joe-Marc Chauvin et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
TIGIT predominantly regulates the immune response via regulatory T cells
Sema Kurtulus et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226
Christopher A. Fuhrman et al.
JOURNAL OF IMMUNOLOGY (2015)
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function
Robert J. Johnston et al.
CANCER CELL (2014)
Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
Nicole Joller et al.
IMMUNITY (2014)
IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients
Geok Choo Sim et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR
Noa Stanietsky et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
ICOS Regulates the Generation and Function of Human CD4+ Treg in a CTLA-4 Dependent Manner
Jian Zheng et al.
PLOS ONE (2013)
OUTCOMES IN CRITICALLY ILL CANCER PATIENTS WITH SEPTIC SHOCK OF PULMONARY ORIGIN
Etienne de Montmollin et al.
SHOCK (2013)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
The TIGIT/CD226 Axis Regulates Human T Cell Function
Ester Lozano et al.
JOURNAL OF IMMUNOLOGY (2012)
Vstm3 is a member of the CD28 family and an important modulator of T-cell function
Steven D. Levin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Prevention of Lymphocyte Apoptosis in Septic Mice with Cancer Increases Mortality
Amy C. Fox et al.
JOURNAL OF IMMUNOLOGY (2011)
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
Nicole Joller et al.
JOURNAL OF IMMUNOLOGY (2011)
DOSE-DEPENDENT EFFECT OF ANTI-CTLA-4 ON SURVIVAL IN SEPSIS
Shigeaki Inoue et al.
SHOCK (2011)
Cancer causes increased mortality and is associated with altered apoptosis in murine sepsis
Amy C. Fox et al.
CRITICAL CARE MEDICINE (2010)
Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis
Pavan Brahmamdam et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
Xin Yu et al.
NATURE IMMUNOLOGY (2009)
The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data
Alexander Melamed et al.
CRITICAL CARE (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
The epidemiology of sepsis in patients with malignancy
Pajman A. Danai et al.
CHEST (2006)
Evaluation of endotoxin models for the study of sepsis
DG Remick et al.
SHOCK (2005)
Share Paper
